| Using Resistin, glucose, age and BMI to predict the presence of breast cancer M Patrício, J Pereira, J Crisóstomo, P Matafome, M Gomes, R Seiça, ... BMC cancer 18, 1-8, 2018 | 325 | 2018 |
| Methylglyoxal promotes oxidative stress and endothelial dysfunction CM Sena, P Matafome, J Crisóstomo, L Rodrigues, R Fernandes, ... Pharmacological Research 65 (5), 497-506, 2012 | 241 | 2012 |
| Methylglyoxal, obesity, and diabetes P Matafome, C Sena, R Seiça Endocrine 43, 472-484, 2013 | 204 | 2013 |
| Metformin restores endothelial function in aorta of diabetic rats CM Sena, P Matafome, T Louro, E Nunes, R Fernandes, RM Seiça British journal of pharmacology 163 (2), 424-437, 2011 | 196 | 2011 |
| Irisin and myonectin regulation in the insulin resistant muscle: implications to adipose tissue: muscle crosstalk L Gamas, P Matafome, R Seiça Journal of diabetes research 2015 (1), 359159, 2015 | 161 | 2015 |
| Metformin and atorvastatin combination further protect the liver in type 2 diabetes with hyperlipidaemia P Matafome, T Louro, L Rodrigues, J Crisostomo, E Nunes, C Amaral, ... Diabetes/metabolism research and reviews 27 (1), 54-62, 2011 | 101 | 2011 |
| Ischaemia-induced autophagy leads to degradation of gap junction protein connexin43 in cardiomyocytes. T Martins-Marques, S Catarino, M Zuzarte, C Marques, P Matafome, ... Biochemical Journal 467 (2), 2015 | 100 | 2015 |
| Methylglyoxal in metabolic disorders: facts, myths, and promises P Matafome, T Rodrigues, C Sena, R Seiça Medicinal research reviews 37 (2), 368-403, 2017 | 95 | 2017 |
| Hyperresistinemia and metabolic dysregulation: a risky crosstalk in obese breast cancer J Crisostomo, P Matafome, D Santos-Silva, AL Gomes, M Gomes, ... Endocrine 53, 433-442, 2016 | 89 | 2016 |
| MicroRNA-424 (322) as a new marker of disease progression in pulmonary arterial hypertension and its role in right ventricular hypertrophy by targeting SMURF1 R Baptista, C Marques, S Catarino, FJ Enguita, MC Costa, P Matafome, ... Cardiovascular research 114 (1), 53-64, 2018 | 85 | 2018 |
| Methylglyoxal‐induced imbalance in the ratio of vascular endothelial growth factor to angiopoietin 2 secreted by retinal pigment epithelial cells leads to endothelial dysfunction CF Bento, R Fernandes, P Matafome, C Sena, R Seica, P Pereira Experimental physiology 95 (9), 955-970, 2010 | 79 | 2010 |
| The force at the tip-modelling tension and proliferation in sprouting angiogenesis P Santos-Oliveira, A Correia, T Rodrigues, TM Ribeiro-Rodrigues, ... PLoS computational biology 11 (8), e1004436, 2015 | 74 | 2015 |
| Methylglyoxal causes structural and functional alterations in adipose tissue independently of obesity P Matafome, D Santos-Silva, J Crisóstomo, T Rodrigues, L Rodrigues, ... Archives of physiology and biochemistry 118 (2), 58-68, 2012 | 72 | 2012 |
| Lactation as a programming window for metabolic syndrome C Picó, F Reis, C Egas, P Mathias, P Matafome European Journal of Clinical Investigation 51 (5), e13482, 2021 | 68 | 2021 |
| Functional abolition of carotid body activity restores insulin action and glucose homeostasis in rats: key roles for visceral adipose tissue and the liver JF Sacramento, MJ Ribeiro, T Rodrigues, E Olea, BF Melo, MP Guarino, ... Diabetologia 60 (1), 158-168, 2017 | 65 | 2017 |
| Antioxidant and vascular effects of gliclazide in type 2 diabetic rats fed high-fat diet CM Sena, T Louro, P Matafome, E Nunes, P Monteiro, R Seiça Institute of Physiology, Czech Academy of Sciences, 2009 | 65 | 2009 |
| Common mechanisms of dysfunctional adipose tissue and obesity‐related cancers P Matafome, D Santos‐Silva, CM Sena, R Seiça Diabetes/metabolism research and reviews 29 (4), 285-295, 2013 | 59 | 2013 |
| Methylglyoxal-induced glycation changes adipose tissue vascular architecture, flow and expansion, leading to insulin resistance T Rodrigues, P Matafome, J Sereno, J Almeida, J Castelhano, L Gamas, ... Scientific reports 7 (1), 1698, 2017 | 58 | 2017 |
| Function and dysfunction of adipose tissue P Matafome, R Seiça Obesity and brain function, 3-31, 2017 | 55 | 2017 |
| Dopamine D2 receptor agonist, bromocriptine, remodels adipose tissue dopaminergic signalling and upregulates catabolic pathways, improving metabolic profile in type 2 diabetes G Tavares, D Marques, C Barra, D Rosendo-Silva, A Costa, T Rodrigues, ... Molecular metabolism 51, 101241, 2021 | 54 | 2021 |
